Dianthus Therapeutics (DNTH) PT Raised to $132 at Jefferies
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $108.14 +0.27%
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 4
Rating Summary:
16 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 4
Join SI Premium – FREE
Jefferies analyst Maury Raycroft raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $132.00 (from $110.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi initiates Dianthus Therapeutics coverage with Buy rating
- Equity Bancshares (EQBK) PT Raised to $54 at DA Davidson
- Broadcom Limited (AVGO) PT Lowered to $350 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
